How can analytical diagnostics in clinical toxicology be successfully performed today?

Therapeutic Drug Monitoring

Volumn 34, Issue 5, 2012, Pages 561-564

  Maurer, Hans H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

emergency toxicology; GC MS; LC MS; quantification; screening

Indexed keywords

4 HYDROXYBUTYRIC ACID; DESIGNER DRUG; DIETHYLENE GLYCOL; ETHYLENE GLYCOL; GLYCOLIC ACID; LACTIC ACID; PARACETAMOL; PHENOBARBITAL; PHENYLENEDIAMINE; PHENYTOIN; PRIMIDONE; PROPYLENE GLYCOL; SALICYLIC ACID; TETRAETHYLENE GLYCOL; TRIETHYLENE GLYCOL; UNCLASSIFIED DRUG; VALPROIC ACID;

ARTICLE; BLOOD EXAMINATION; BLOOD SAMPLING; DIAGNOSTIC PROCEDURE; DRUG ABUSE; DRUG INTOXICATION; DRUG SCREENING; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; METHEMOGLOBINEMIA; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; RHABDOMYOLYSIS; TOXICOLOGY; URINALYSIS;

ANIMALS; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MASS SPECTROMETRY; POISONS; QUALITY CONTROL; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TOXICOLOGY;

EID: 84866541168     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31826a622d.     Document Type: Article

References (51)

1. Maurer HH. Demands on scientific studies in clinical toxicology. Forensic Sci Int. 2007;165:194-198.
2. Maurer HH. Analytical toxicology. Experientia. 2010;100:317-337.
3. Maurer HH. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control. Clin Chem Lab Med. 2004;42:1310-1324.
4. Maurer HH. Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control. J Mass Spectrom. 2006;41:1399-1413.
5. Flanagan RJ. Developing an analytical toxicology service: principles and guidance. Toxicol Rev. 2004;23:251-263.
6. Flanagan RJ, Connally G, Evans JM. Analytical toxicology: guidelines for sample collection postmortem. Toxicol Rev. 2005;24:63-71.
7. Wu AH, McKay C, Broussard LA, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003;49:357-379.
8. Boyer EW, Shannon MW. Which drug tests in medical emergencies? Clin Chem. 2003;49:353-354.
9. Bailey B, Amre DK. A toxicologist's guide to studying diagnostic tests. Clin Toxicol (Phila). 2005;43:171-179.
10. Tenenbein M. Do you really need that emergency drug screen? Clin Toxicol (Phila). 2009;47:286-291.
11. Meyer MR, Peters FT, Maurer HH. Automated mass spectral deconvo-lution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clin Chem. 2010;56:575-584.
12. Maurer HH, Pfleger K, Weber AA, eds. Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and their Metabolites. 4th ed. Weinheim, Germany: Wiley-VCH; 2011.
13. Wissenbach DK, Meyer MR, Remane D, et al. Development of the first metabolite-based LC-MSn urine drug screening procedure-exemplified for antidepressants. Anal Bioanal Chem. 2011;400:79-88.
14. Ojanpera I, Kolmonen M, Pelander A. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal Bioanal Chem. 2012;403:1203-1220.
15. Dulaurent S, Moesch C, Marquet P, et al. Screening of pesticides in blood with liquid chromatography-linear ion trap mass spectrometry. Anal Bioanal Chem. 2010;396:2235-2249.
16. Sturm S, Hammann F, Drewe J, et al. An automated screening method for drugs and toxic compounds in human serum and urine using liquid chromatography-tandem mass spectrometry. J Chromatogr B. 2010;878:2726-2732.
17. Lynch KL, Breaud AR, Vandenberghe H, et al. Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening. Clin Chim Acta. 2010;411:1474-1481.
18. Mueller DM, Duretz B, Espourteille FA, et al. Development of a fully automated toxicological LC-MS(n) screening system in urine using online extraction with turbulent flow chromatography. Anal Bioanal Chem. 2011;400:89-100.
19. Wissenbach DK, Meyer MR, Remane D, et al. Drugs of abuse screening in urine as part of a metabolite-based LC-MS(n) screening concept. Anal Bioanal Chem. 2011;400:3481-3489.
20. Sauvage FL, Saint-Marcous F, Duretz B, et al. Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clin Chem. 2006;52:1735-1742.
21. Sauvage FL, Picard N, Saint-Marcoux F, et al. General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: applications and constraints. J Sep Sci. 2009;32:3074-3083.
22. Dresen S, Gergov M, Politi L, et al. ESI-MS/MS library of 1, 253 compounds for application in forensic and clinical toxicology. Anal Bioanal Chem. 2009;395:2521-2526.
23. Picard N, Dridi D, Sauvage FL, et al. General unknown screening procedure for the characterization of human drug metabolites: application to loratadine phase I metabolism. J Sep Sci. 2009;32:2209-2217.
24. Dresen S, Ferreiros N, Gnann H, et al. Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP LC-MS/MS system and library searching. Anal Bioanal Chem. 2010;396:2425-2434.
25. Viette V, Guillarme D, Mylonas R, et al. A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part I). Clin Biochem. 2011;44:32-44.
26. Viette V, Guillarme D, Mylonas R, et al. A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (part II). Clin Biochem. 2011;44:45-53.
27. Gonzalez O, Alonso RM, Ferreiros N, et al. Development of an LC-MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy. J Chromatogr B. 2011;879:243-252.
28. Pavlic M, Libiseller K, Oberacher H. Combined use of ESI-QqTOF-MS and ESI-QqTOF-MS/MS with mass-spectral library search for qualitative analysis of drugs. Anal Bioanal Chem. 2006;386:69-82.
29. Lee HK, Ho CS, Iu YP, et al. Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of-flight mass spectrometry. Anal Chim Acta. 2009;649:80-90.
30. Broecker S, Herre S, Wust B, et al. Development and practical application of a library of CID accurate mass spectra of more than 2, 500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition. Anal Bioanal Chem. 2011;400:101-117.
31. Kirchherr H, Kuhn-Velten WN. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J Chromatogr B. 2006;843:100-113.
32. Sauvage FL, Gaulier JM, Lachatre G, et al. A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum. Ther Drug Monit. 2006; 28:123-130.
33. Meyer MR, Weber AA, Maurer HH. A validated GC-MS procedure for fast, simple, and cost-effective quantification of glycols and GHB in human plasma and their identification in urine and plasma developed for emergency toxicology. Anal Bioanal Chem. 2011;400:411-414.
34. Meyer MR, Welter J, Weber AA, et al. Development, validation, and application of a fast and simple GC-MS method for determination of some therapeutic drugs relevant in emergency toxicology. Ther Drug Monit. 2011;33:649-653.
35. Remane D, Meyer MR, Wissenbach DK, et al. Full validation and application of an ultra high performance liquid chromatographic-tandem mass spectrometric procedure for target screening and quantification of 34 antidepressants in human blood plasma as part of a comprehensive multi-analyte approach. Anal Bioanal Chem. 2011;400:2093-2107.
36. Remane D, Meyer MR, Wissenbach DK, et al. Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs. Anal Bioanal Chem. 2011;401:1341-1352.
37. del Mar Ramírez Fernández M, Wille SM, Samyn N. Quantitative method validation for the analysis of 27 antidepressants and metabolites in plasma with ultraperformance liquid chromatography-tandem mass spectrometry. Ther Drug Monit. 2012;34:11-24.
38. von Mach M-A, Weber C, Meyer MR, et al. Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrom-etry results of 111 patients with suspected poisoning presenting at an emergency department. Ther Drug Monit. 2007;29:27-39.
39. Maurer HH. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem. 2007;388:1315-1325.
40. Maurer HH. Mass spectrometric approaches in impaired driving toxicology. Anal Bioanal Chem. 2009;393:97-107.
41. Peters FT. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem. 2010; 44:54-65.
42. Maurer HH. Forensic screening with GC-MS. In: Bogusz M, ed. Handbook of Analytical Separation Sciences: Forensic Sciences. 2nd ed. Amsterdam, Netherlands: Elsevier Science; 2007:429-449.
43. Maurer HH, Pfleger K, Weber AA, eds. Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants and their Metabolites. 4th Rev ed. Weinheim, Germany: Wiley-VCH; 2011.
44. McLafferty FW, ed. Wiley Registry of Mass Spectral Data. 9th ed. With NIST 2011 Spectral Data. New York: John Wiley & Sons; 2011.
45. Josephs JL, Sanders M. Creation and comparison of MS/MS spectral libraries using quadrupole ion trap and triple-quadrupole mass spectrometers. Rapid Commun Mass Spectrom. 2004;18:743-759.
46. Hopley C, Bristow T, Lubben A, et al. Towards a universal product ion mass spectral library-reproducibility of product ion spectra across eleven different mass spectrometers. Rapid Commun Mass Spectrom. 2008;22:1779-1786.
47. Wissenbach DK, Meyer MR, Weber AA, et al. Towards a universal LC-MS screening procedure-can an LIT LC-MSn screening approach and reference library be used on a quadrupole-LIT hybrid instrument? J Mass Spectrom. 2012;47:66-71.
48. Staack RF, Maurer HH. New Bühlmann ELISA for determination of amanitins in urine-are there false positive results due to interferences with urine matrix, drugs or their metabolites? Toxichem Krimtech. 2001; 68:68-71.
49. Peters FT, Maurer HH. Bioanalytical method validation and its implications for forensic and clinical toxicology-a review. Accred Qual Assur. 2002;7:441-449.
50. Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Sci Int. 2007;165:216-224.
51. Peters FT, Paul LD, Musshoff F, et al. Guidelines for quality assurance in forensic-toxicological analyses. Toxichem Krimtech. 2009;76:185-208.